Products & Services · Cost of Sales

Product revenues, net — Cost of Sales

Vertex Pharmaceuticals Product revenues, net — Cost of Sales decreased by 16.0% to $160.20M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 22.7%, from $130.60M to $160.20M. Over 3 years (FY 2022 to FY 2025), Product revenues, net — Cost of Sales shows an upward trend with a 32.2% CAGR.

Analysis

StatementSegment
First reportedQ1 2022
Last reportedQ1 2026May 5, 2026
Rolls up toTotal Cost of Revenue
Metric ID: vrtx_segment_product_revenues_net_cost_of_sales

Historical Data

17 periods
 Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$65.13M$65.13M$65.13M$65.13M$87.30M$87.30M$87.30M$87.30M$108.80M$123.50M$131.60M$152.40M$130.60M$140.50M$139.60M$190.80M$160.20M
QoQ Change—+0.0%+0.0%+0.0%+34.0%+0.0%+0.0%+0.0%+24.6%+13.5%+6.6%+15.8%-14.3%+7.6%-0.6%+36.7%-16.0%
YoY Change————+34.0%+34.0%+34.0%+34.0%+24.6%+41.5%+50.7%+74.6%+20.0%+13.8%+6.1%+25.2%+22.7%
Range$65.13M – $190.80M
CAGR+25.2%
Avg YoY Growth+32.0%
Median YoY Growth+34.0%

Frequently Asked Questions

What is Vertex Pharmaceuticals's product revenues, net — cost of sales?
Vertex Pharmaceuticals (VRTX) reported product revenues, net — cost of sales of $160.20M in Q1 2026.
How has Vertex Pharmaceuticals's product revenues, net — cost of sales changed year-over-year?
Vertex Pharmaceuticals's product revenues, net — cost of sales increased by 22.7% year-over-year, from $130.60M to $160.20M.
What is the long-term trend for Vertex Pharmaceuticals's product revenues, net — cost of sales?
Over 3 years (2022 to 2025), Vertex Pharmaceuticals's product revenues, net — cost of sales has grown at a 32.2% compound annual growth rate (CAGR), from $260.50M to $601.50M.